militari
recruit
receiv
train
histor
vulner
acut
respiratori
diseas
ard
increas
suscept
attribut
demand
physic
train
schedul
crowd
habit
adenovirus
influenza
b
virus
streptococcu
pneumonia
streptococcu
pyogen
chlamydia
pneumonia
mycoplasma
pneumonia
viru
coronaviru
rhinovirus
previous
identifi
caus
ard
among
militari
popul
infect
agent
extens
studi
set
howev
signific
proport
ill
attribut
unknown
caus
agent
probabl
unidentifi
respiratori
virus
human
respiratori
syncyti
viru
rsv
envelop
rna
viru
genu
pneumoviru
rsv
infect
long
acknowledg
singl
import
viral
pathogen
lead
caus
sever
lower
respiratori
tract
infect
infant
young
children
howev
decad
rsv
increasingli
recogn
caus
sever
lower
respiratori
tract
ill
certain
suscept
adult
popul
includ
elderli
immunocompromis
sever
underli
patholog
rsv
infect
howev
limit
paediatr
certain
adult
acquir
immun
rsv
partial
transient
natur
occur
repeatedli
throughout
life
acut
respiratori
ill
result
rsv
infect
identifi
previous
healthi
immunocompet
adult
although
clinic
sever
infect
subsequ
typic
diminish
spectrum
diseas
vari
wide
role
rsv
caus
respiratori
diseas
among
recruit
train
yet
fulli
determin
previou
epidemiolog
studi
limit
studi
rsv
acut
respiratori
infect
adult
remain
challeng
difficulti
diagnosi
primarili
due
shed
low
viral
titr
upper
respiratori
tract
secret
adult
short
durat
thermolabil
natur
rsv
presenc
nasal
antibodi
preliminari
studi
set
estim
preval
clinic
signific
rsv
infect
character
ill
associ
rsv
determin
preval
clinic
characterist
common
viral
agent
popul
royal
navi
recruit
undergo
basic
train
addit
convent
viral
cultur
techniqu
serolog
recent
describ
novel
highli
sensit
pcr
assay
use
detect
rsv
infect
studi
particip
symptomat
militari
recruit
receiv
basic
train
hm
raleigh
larg
royal
navi
new
entri
train
establish
coast
britain
recruit
elig
enrol
studi
upon
seek
medic
attent
nonspecif
symptom
oral
temperatur
either
cough
sore
throat
recruit
meet
case
definit
receiv
written
verbal
brief
invit
give
voluntari
inform
consent
particip
studi
design
enrol
subject
period
month
begin
novemb
end
april
concurr
annual
epidem
rsv
infect
among
civilian
popul
bilater
nasopharyng
swab
blood
sampl
collect
particip
upon
enrol
addit
studi
particip
complet
case
report
captur
demograph
clinic
data
sampl
store
hour
collect
thereaft
nasopharyng
swab
store
serum
sampl
follow
separ
centrifug
week
follow
initi
present
particip
recal
convalesc
serum
sampl
collect
questionnair
regard
natur
sever
durat
specifi
symptom
effect
train
complet
viru
isol
identif
perform
use
standard
procedur
six
tissu
cultur
cell
line
use
includ
human
epitheli
cell
primari
rhesu
monkey
kidney
cell
human
lung
fibroblast
human
lung
mucoepidermoid
cell
human
lung
adenocarcinoma
cell
mix
monolay
mink
lung
cell
multipl
cell
line
use
facilit
detect
varieti
respiratori
virus
includ
rsv
influenza
virus
b
parainfluenza
virus
piv
adenoviru
enteroviru
herp
simplex
virus
hsv
cultur
examin
light
microscopi
characterist
viral
cytopath
effect
immunofluoresc
use
panel
monoclon
antibodi
direct
respiratori
virus
provid
viral
identif
elisa
modifi
standard
method
use
determin
serum
igg
antibodi
rsv
pool
rsv
b
cell
lysat
posit
antigen
control
cell
lysat
neg
antigen
prepar
optim
antigen
dilut
determin
incub
time
wash
condit
detect
condit
previous
describ
pair
sera
assay
two
screen
dilut
subsequ
sampl
demonstr
greater
optic
densiti
ratio
subsequ
assay
sever
serial
doubl
dilut
antibodi
respons
rsv
consid
posit
pair
sampl
possess
serum
optic
densiti
demonstr
increas
igg
antibodi
acut
convalesc
sampl
highli
sensit
pcr
assay
employ
molecular
beacon
probe
use
detect
rsv
rna
respiratori
secret
deriv
nasopharyng
swab
sampl
follow
rna
isol
cdna
synthesi
nest
pcr
molecular
beacon
pcr
product
analysi
perform
previous
describ
pcr
perform
triplic
sampl
posit
presenc
rsv
determin
mean
cycl
threshold
ct
valu
quantif
rsv
titr
calcul
interpol
mean
specimen
ct
valu
use
previous
gener
standard
refer
curv
week
period
earli
januari
late
march
symptomat
traine
enrol
studi
group
recruit
met
case
definit
averag
resid
popul
recruit
hm
raleigh
approxim
period
nasopharyng
swab
acut
phase
blood
sampl
complet
case
report
obtain
recruit
present
questionnair
complet
recruit
particip
detail
present
subsequ
gather
gener
clinic
inform
summar
tabl
one
virus
isol
identifi
viral
cultur
particip
adenoviru
isol
recruit
influenza
virus
recruit
influenza
influenza
b
viru
occur
alon
identifi
respiratori
virus
ie
rsv
piv
enteroviru
hsv
isol
viral
cultur
pair
sera
avail
particip
determin
igg
antibodi
titr
perform
sampl
elisa
among
recruit
three
demonstr
serolog
evid
recent
rsv
infect
indic
increas
igg
antibodi
acut
convalesc
sera
two
traine
show
twofold
increas
igg
titr
traine
show
chang
titr
remain
five
traine
demonstr
reduct
igg
titr
two
pair
sampl
exclud
analysi
indetermin
igg
titr
haemolysi
molecular
beacon
nest
pcr
detect
presenc
rsv
rna
sampl
convent
nest
pcr
fail
detect
presenc
rsv
rna
sampl
estim
rna
level
posit
sampl
rang
equival
pfuml
mean
pfuml
assay
detect
virion
rna
viral
mrna
respiratori
syncyti
viru
detect
among
six
differ
recruit
either
pcr
serolog
therefor
combin
data
preval
rsv
among
particip
determin
addit
preval
determin
three
recruit
posit
rsv
infect
serolog
differ
three
recruit
posit
pcr
clinic
data
associ
identifi
viru
summar
tabl
similar
studi
older
studi
respiratori
ill
associ
rsv
militari
traine
report
preval
recent
studi
civilian
popul
young
adult
determin
preval
present
studi
traine
experienc
upper
respiratori
tract
ill
last
sever
day
addit
report
occurr
wheez
day
durat
consist
recent
studi
note
involv
lower
respiratori
tract
adult
infect
rsv
recruit
absent
train
almost
week
confin
sickbay
illustr
degre
morbid
associ
rsv
infect
popul
among
sampl
found
posit
rsv
pcr
serolog
viral
cultur
fail
detect
viru
consist
present
view
viral
cultur
optimum
diagnost
test
detect
rsv
adult
insensit
techniqu
poor
correl
result
molecular
serolog
method
may
due
numer
factor
includ
shed
low
viral
titr
respiratori
secret
short
period
presenc
inhibitor
secret
extrem
labil
viru
condit
sampl
collect
storag
transport
addit
shown
serolog
respons
young
healthi
adult
rsv
may
diminish
compar
elderli
thu
support
current
consensu
combin
pcr
serolog
optim
method
detect
rsv
infect
popul
larger
studi
would
undoubtedli
yield
valuabl
inform
relationship
true
infect
rsv
isol
presenc
absenc
magnitud
immun
respons
determin
serolog
final
overal
incid
rsv
infect
like
higher
recruit
mild
upper
respiratori
tract
symptom
includ
studi
meet
stringent
case
definit
common
respiratori
viru
isol
symptomat
recruit
adenoviru
first
account
respiratori
ill
british
militari
traine
observ
preval
similar
note
recent
studi
adenoviru
infect
us
militari
train
centr
significantli
greater
estim
infect
civilian
adult
studi
recruit
experienc
upper
respiratori
tract
symptom
report
symptom
lower
respiratori
tract
diseas
includ
wheez
dyspnoea
furthermor
confirm
adenoviru
infect
hospit
pneumonia
consist
view
infect
adenoviru
typic
character
upper
respiratori
diseas
may
progress
involv
lower
respiratori
tract
addit
almost
traine
experienc
absenc
train
consider
proport
anoth
unit
recycl
train
adenovirus
particularli
serotyp
recogn
import
caus
ard
among
young
adult
undergo
basic
militari
train
sinc
consist
isol
us
militari
recruit
ard
larg
epidem
train
centr
could
incapacit
command
halt
train
programm
seriou
repercuss
militari
readi
us
depart
defens
began
routin
administr
live
attenu
vaccin
adenoviru
type
militari
recruit
dramat
impact
recruit
ill
reduc
total
respiratori
diseas
rate
reduc
diseas
promptli
halt
diseas
epidem
recruit
sole
manufactur
ceas
product
adenovir
vaccin
follow
extens
ration
exist
product
vaccin
avail
use
sinc
earli
suppli
gradual
declin
outbreak
adenovir
respiratori
ill
us
militari
train
establish
adenoviru
morbid
markedli
increas
view
adenoviru
infect
us
depart
defens
contract
new
vaccin
manufactur
produc
adenoviru
vaccin
present
studi
provid
preliminari
data
debat
concern
relev
programm
british
recruit
influenza
virus
associ
symptomat
infect
traine
case
acut
upper
respiratori
tract
ill
result
although
lower
respiratori
tract
diseas
occasion
occur
almost
recruit
experienc
absenc
train
signific
number
confin
sickbay
influenza
particular
import
popul
militari
popul
high
risk
infect
inactiv
influenza
vaccin
shown
safe
immunogen
highli
efficaci
reduc
febril
respiratori
ill
caus
influenza
adult
popul
addit
influenza
vaccin
shown
rel
provid
either
support
care
alon
treatment
neuraminidas
inhibitor
influenza
vaccin
programm
militari
basic
traine
current
polici
usa
uk
vaccin
administ
within
first
day
train
although
efficaci
programm
prevent
influenz
infect
traine
may
consider
depend
congruiti
vaccin
circul
strain
may
occas
present
studi
uniqu
first
report
respiratori
tract
ill
associ
adenovir
rsv
infect
symptomat
british
militari
recruit
addit
although
involv
rel
small
number
subject
studi
provid
preliminari
data
support
employ
adenoviru
influenza
vaccin
popul
valid
expans
studi
research
includ
evalu
vaccin
would
seem
appropri
next
step
ethic
approv
grant
defenc
medic
servic
clinic
research
committe
protocol
studi
conduct
complianc
applic
regul
govern
protect
human
subject
research
view
express
articl
author
reflect
offici
polici
posit
royal
navi
ministri
defenc
british
govern
us
depart
navi
us
depart
defens
us
govern
dr
gray
serv
data
monitor
committe
duram
inc
us
manufactur
adenoviru
vaccin
